Skip to main content
Daniel Tsai on Muck Rack

Daniel Tsai

Canada
As seen in: The Toronto Star, Nature, Wiley Online Library, Yahoo Canada, Cambridge University Press & Assessment, PLOS Medicine, MDPI, The Conversation, The Globe and Mail, JAMA (The Journal of the American Medical Association), Phys.org and
Lawyer, MBA, Professor Univ of Toronto, iHeart Radio's Business, Law & Tech Expert, Cornell alum, Ex Senior Policy Advisor, Columnist, Editor ConsumerRights.ca

Get in touch with Daniel

Contact Daniel, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Daniel Tsai’s Journalist Portfolio

Why bringing the legends back to life through AI is good for the music industry

Why bringing the legends back to life through AI is good for the music industry

Music giants that once fought the scraping of song catalogues, writes Daniel Tsai, are now negotiating how to…

View article →
Governments fiddle while the Earth burns: What Canada can do to lead on ESG

Governments fiddle while the Earth burns: What Canada can do to lead on ESG

McGill University's CIBC Office of Sustainable Finance proposes reforms to encourage corporations to address …

View article →
Why a universal job guarantee should be Justin Trudeau's legacy

Why a universal job guarantee should be Justin Trudeau's legacy

Pierre Trudeau had the Charter. Brian Mulroney had free trade. A job guarantee may be the signature achieveme…

View article →
Donald Trump has slammed the door on a skilled immigrant workforce. Canada should open it

Donald Trump has slammed the door on a skilled immigrant workforce. Canada should open it

Washington's assault on skilled immigrants is self-sabotage - and a golden opportunity for Canada, writes Dan…

View article →

Articles

Comparison of adverse renal events between ranibizumab and aflibercept in patients with diabetic macular oedema: A global network study

|
By Wan-Ju Lee, Daniel Tsai, Michael Cheng, Yu-Shiuan Lin, Chia-Yi Lee, Shih-Chieh Shao, Edward Chia-Cheng Lai
| Nature Verified
Abstract Patients with diabetic macular oedema (DMO) are susceptible to renal injury, raising the risks of acute kidney injury (AKI) and end-stage renal disease (ESRD) associated with anti-VEGF therapies. We aimed to compare the risks of AKI and ESRD between aflibercept and ranibizumab in DMO patients, focusing on AKI and ESRD in conjunction with all-cause mortality.
Open in Who Shared Issue with article?

Hyperuricemia risk in bempedoic acid-treated hyperlipidemic patients

|
By Po-Hsueh Su, Daniel Tsai, Miyuki Hsing-Chun Hsieh, Tharmaraj Vairaperumal, Edward Chia-Cheng Lai, Ping-Yen Liu
| Nature Verified
Abstract Bempedoic acid is an oral cholesterol-lowering medication used to reduce low-density lipoprotein cholesterol (LDL-C), particularly in patients who require additional lipid lowering. Clinical trials have shown that bempedoic acid increases serum uric acid levels, but the implications of this effect in real-world clinical practice, including the need for anti-gout treatment, are not well defined.
Open in Who Shared Issue with article?

Association Between Pneumonia Risk and Anticholinergic Burden Among Patients with Different Frailty Levels [Response to Letter]

|
By Avery Yang, Hsin-Yu Chiang, Daniel Tsai
| Dove Medical Press
Back to Journals » Clinical Epidemiology » Volume 18 Authors Yang ASH , Fan Chiang HY, Tsai DHT , Chuang ATM, Lai ECC Received 17 March 2026 Accepted for publication 3 April 2026 Published 30 April 2026 Volume 2026:18 609824 DOI https://doi.org/10.2147/CLEP.S609824 Avery Shuei-He Yang,1,2 Hsin-Yu Fan Chiang,1 Daniel Hsiang-Te Tsai,1,2 Albert Tzu-Ming Chuang,1,2 Edward Chia-Cheng Lai1,2 1School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine,...
Open in Who Shared Issue with article?
See all 117 licensed articles (119 Total)